Company Monitoring Page for MannKind

latest headlines for company on cafepharma

Will FDA Labelling Be MannKind's Downfall?
Motley Fool
Thu, 07/24/14 - 08:31 am
Tags:
FDA, labeling, diabetes, Afrezza, MannKind
Afrezza Is A Brilliant Technology Without A Compelling Marketing Story
Seeking Alpha
Wed, 07/23/14 - 06:14 pm
Tags:
Afrezza, diabetes, MannKind, inhaled insulin
5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise
Seeking Alpha
Mon, 07/21/14 - 10:19 am
Tags:
MannKind, Afrezza, diabetes, AstraZeneca, GSK, Eli Lilly, Novo Nordisk, Merck
Is This MannKind's Greatest Risk?
Motley Fool
Sat, 07/12/14 - 10:39 am
Tags:
MannKind, Afrezza
Should AstraZeneca Buy MannKind?
Motley Fool
Tue, 07/1/14 - 11:55 pm
Tags:
MannKind, diabetes, Afrezza, M&A, AstraZeneca
Why Merck Should Buy Inovio, Seattle Genetics, or MannKind
Motley Fool
Tue, 07/1/14 - 10:37 am
Tags:
Merck, M&A, Inovio, Seattle Genetics, MannKind
MannKind's Afrezza Approved but Will Doctors Prescribe It?
Motley Fool
Mon, 06/30/14 - 05:45 pm
Tags:
MannKind, Afrezza, insulin, diabetes, inhaled insulin
MannKind’s Afrezza: Too Niche?
Barron's
Mon, 06/30/14 - 11:06 am
Tags:
MannKind, Afrezza, diabetes, insulin, inhaled insulin
Afrezza Approval Opens The Door To Multi-Billion Dollar Markets For MannKind
Seeking Alpha
Mon, 06/30/14 - 10:07 am
Tags:
FDA, inhaled insulin, insulin, Afrezza, MannKind, diabetes
MannKind: No Surprises, Big Hit
Barron's
Sat, 06/28/14 - 10:33 am
Tags:
MannKind, inhaled insulin, Afrezza, diabetes
MannKind Wins U.S. FDA Approval for Inhaled Insulin
Bloomberg
Fri, 06/27/14 - 05:30 pm
Tags:
MannKind, FDA, inhaled insulin, Afrezza, diabetes, insulin
MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm
Seeking Alpha
Fri, 06/27/14 - 09:47 am
Tags:
MannKind, Afrezza, diabetes, FDA
Is This MannKind's Biggest Risk?
Motley Fool
Thu, 06/19/14 - 09:22 am
Tags:
MannKind, diabetes, Afrezza
Are Investors Overestimating The Market For MannKind's Afrezza?
Seeking Alpha
Mon, 06/16/14 - 08:32 pm
Tags:
MannKind, diabetes, Afrezza
Will These 3 Products Revolutionize Diabetes Treatment?
Motley Fool
Sun, 06/15/14 - 06:58 pm
Tags:
diabetes, MannKind, Afrezza, Novo Nordisk, Apple
MannKind Entertaining Multiple Partnership Possibilities Ahead Of FDA Decision On Afrezza
Seeking Alpha
Fri, 06/13/14 - 12:28 pm
Tags:
MannKind, FDA, Afrezza, diabetes
The Expected Rise and Inevitable Fall of MannKind
TheStreet.com
Thu, 06/5/14 - 09:27 am
Tags:
MannKind, Afrezza, diabetes, Arena Pharmaceuticals, Belviq
As Predicted, MannKind Starting Emotionally Fueled Run To FDA Approval, When It May Be Best To Go Short
Seeking Alpha
Tue, 06/3/14 - 11:02 am
Tags:
FDA, diabetes, inhaled insulin, MannKind, Afrezza
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
Tue, 05/27/14 - 11:53 am
Tags:
AcelRx, Anacor, BioDelivery Sciences, Eagle Pharmaceuticals, MannKind, Navidea Biopharmaceuticals, Orexigen, Omeros, EnteroMedics, Progenics, Trimel Pharmaceuticals
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision
Seeking Alpha
Mon, 05/19/14 - 10:45 am
Tags:
MannKind, diabetes, inhaled insulin, Afrezza

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.